Glassman Wealth Services Arrowhead Pharmaceuticals, Inc. Transaction History

Glassman Wealth Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$39.62 - $69.97 $475 - $839	-12 Reduced 80.0%	3 $0
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $580 - $825	10 Added 200.0%	15 $1,000
Q1 2021 May 05, 2021	BUY	$61.35 - $90.47 $122 - $180	2 Added 66.67%	5 $0
Q1 2020 May 12, 2020	SELL	$20.56 - $63.12 $102 - $315	-5 Reduced 62.5%	3 $0
Q2 2019 Aug 08, 2019	BUY	$17.43 - $28.82 $139 - $230	8 New	8 $0

295

92.3M

1.33M

549K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.